Neurologic clinical trial - Janssen Momenta MOM-M281-011

Neurologic

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT04951622

Janssen Momenta MOM-M281-011

Phase

Phase II

Condition

Myasthenia gravis

Keywords

Myasthenia gravis | generalized myasthenia gravis | MG